CD56 Is an Unfavorable Prognostic Factor for Acute Promyelocytic Leukemia: Results By Multivariate Analyses in the JALSG-APL204 Study

被引:0
|
作者
Takeshita, Akihiro [1 ]
Asou, Norio [2 ]
Atsuta, Yoshiko [3 ]
Furumaki, Hiroaki [1 ]
Sakura, Toru [4 ]
Ueda, Yasunori [5 ]
Sawa, Masashi [6 ]
Dobashi, Nobuaki [7 ]
Suzuki, Rikio [8 ]
Taniguchi, Yasuhiro [9 ]
Nakagawa, Masaru [10 ]
Tamaki, Shigehisa [11 ]
Hagihara, Maki [12 ]
Fujimaki, Katsumichi [13 ]
Yokoyama, Yasuhisa [14 ]
Fujita, Hiroyuki [15 ]
Yanada, Masamitsu [16 ]
Maeda, Yoshinobu [17 ]
Usui, Noriko [18 ]
Kobayashi, Yukio [19 ]
Kiyoi, Hitoshi [20 ]
Ohtake, Shigeki [21 ]
Matsumura, Itaru [9 ]
Naoe, Tomoki [22 ]
Miyazaki, Yasushi [23 ]
机构
[1] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka, Japan
[2] Saitama Med Univ, Int Med Ctr, Hidaka, Saitama, Japan
[3] Japanese Data Ctr Hematopoiet Cell Transplantat, Nagoya, Aichi, Japan
[4] Saiseikai Maebashi Hosp, Leukemia Res Ctr, Maebashi, Gunma, Japan
[5] Kurashiki Cent Hosp, Dept Haematol Oncol, Kurashiki, Okayama, Japan
[6] Anjo Kosei Hosp, Anjo, Japan
[7] Jikei Univ, Dept Clin Oncol & Hematol, Daisan Hosp, Tokyo, Japan
[8] Tokai Univ, Sch Med, Isahara, Japan
[9] Kindai Univ, Fac Med, Osaka, Japan
[10] Nihon Univ, Sch Med, Tokyo, Japan
[11] Ise Red Cross Hosp, Ise, Japan
[12] Yokohama City Univ, Dept Hematol, Med Ctr, Yokohama, Kanagawa, Japan
[13] Fujisawa City Hosp, Fujisawa, Kanagawa, Japan
[14] Univ Tsukuba, Dept Hematol, Fac Med, Tsukuba, Ibaraki, Japan
[15] Yokohama City Univ, Dept Hematol & Clin Immunol, Grad Sch Med, Yokohama, Kanagawa, Japan
[16] Fujita Hlth Univ, Sch Med, Toyoake, Aichi, Japan
[17] Okayama Univ, Dept Hematol & Oncol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan
[18] Jikei Univ, Dept Internal Med, Div Clin Oncol & Hematol, Sch Med, Tokyo, Japan
[19] IUHW Mita Hosp, Div Hematol, Tokyo, Japan
[20] Nagoya Univ, Dept Hematol & Oncol, Grad Sch Med, Nagoya, Aichi, Japan
[21] Kanazawa Univ, Kanazawa, Ishikawa, Japan
[22] Nagoya Med Ctr, Natl Hosp Org, Nagoya, Aichi, Japan
[23] Nagasaki Univ, Atom Bomb Dis Inst, Nagasaki, Japan
关键词
D O I
10.1182/blood-2018-99-111638
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2798
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Prognostic Significance of CD56 Antigen Expression in Patients with De Novo Non-M3 Acute Myeloid Leukemia
    Sun, Yanni
    Wan, Jia
    Song, Qiuyue
    Luo, Chengxin
    Li, Xi
    Luo, Yanrong
    Huang, Xiangtao
    Ding, Ruiheng
    Hui Li
    Hou, Yu
    Huang, Yongxiu
    Xie, Mingling
    Huang, Zhen
    Zhang, Yali
    Ma, Yanni
    Wu, Guixian
    Xu, Shuangnian
    Chen, Jieping
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [42] Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens
    Montesinos, Pau
    Rayon, Chelo
    Vellenga, Edo
    Brunet, Salut
    Gonzalez, Jose
    Gonzalez, Marcos
    Holowiecka, Aleksandra
    Esteve, Jordi
    Bergua, Juan
    Gonzalez, Jose D.
    Rivas, Concha
    Tormo, Mar
    Rubio, Vicente
    Bueno, Javier
    Manso, Felix
    Milone, Gustavo
    de la Serna, Javier
    Perez, Inmaculada
    Perez-Encinas, Manuel
    Krsnik, Isabel
    Ribera, Josep M.
    Escoda, Lourdes
    Lowenberg, Bob
    Sanz, Miguel A.
    BLOOD, 2011, 117 (06) : 1799 - 1805
  • [43] CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy
    Ferrara, F
    Morabito, F
    Martino, B
    Specchia, G
    Liso, V
    Nobile, F
    Boccuni, P
    Di Noto, R
    Pane, F
    Annunziata, M
    Schiavone, EM
    De Simone, M
    Guglielmi, C
    Del Vecchio, L
    Lo Coco, F
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (06) : 1295 - 1300
  • [44] The Prevalence of CD56 Expression by Flow Cytometry in Acute Promyelocytic Leukemia Patients Treated with All-Trans Retinoic Acid and Anthracycline Drug Combinations
    Olteanu, H.
    Harrington, A. M.
    Kroft, S. H.
    Karandikar, N. J.
    Fuda, F. F.
    LABORATORY INVESTIGATION, 2012, 92 : 359A - 359A
  • [45] The Prevalence of CD56 Expression by Flow Cytometry in Acute Promyelocytic Leukemia Patients Treated with All-Trans Retinoic Acid and Anthracycline Drug Combinations
    Olteanu, H.
    Harrington, A. M.
    Kroft, S. H.
    Karandikar, N. J.
    Fuda, F. F.
    MODERN PATHOLOGY, 2012, 25 : 359A - 359A
  • [46] Multivariate analyses of prognostic factors in acute myeloid leukemia:: relevance of cytogenetic abnormalities and CD34 expression
    Junghanss, C
    Waak, M
    Knopp, A
    Kleine, HD
    Kundt, G
    Leithäuser, M
    Hilgendorf, I
    Wolff, D
    Casper, J
    Freund, M
    NEOPLASMA, 2005, 52 (05) : 402 - 410
  • [47] Prognostic significance of MRD and its correlation with arsenic concentration in pediatric acute promyelocytic leukemia: a retrospective study by SCCLG-APL group
    Fan, Zhong
    Yang, Liang-Chun
    Chen, Yi-Qiao
    Wan, Wu-Qing
    Zhou, Dun-Hua
    Mai, Hui-Rong
    Li, Wan-Li
    Yang, Li-Hua
    Lan, He-Kui
    Chen, Hui-Qin
    Guo, Bi-Yun
    Zhen, Zi-Jun
    Liu, Ri-Yang
    Chen, Guo-Hua
    Feng, Xiao-Qin
    Liang, Cong
    Wang, Li-Na
    Yu-Li, Jie-Si
    Luo, Jie-Si
    Huang, Dan-Ping
    Luo, Xue-Qun
    Li, Bin
    Huang, Li-Bin
    Zhang, Xiao-Li
    Tang, Yan-Lai
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2025, 16
  • [48] Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantation
    Yang, Deok-Hwan
    Lee, Je-Jung
    Mun, Yeung-Chul
    Shin, Ho-Jin
    Kim, Yeo-Kyeoung
    Cho, Sang-Hee
    Chung, Ik-Joo
    Seong, Chu-Myong
    Kim, Hyeoung-Joon
    AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (01) : 1 - 5
  • [49] Impact of additional chromosomal abnormalities in patients with acute promyelocytic leukemia: 10-year results of the Japan Adult Leukemia Study Group APL97 study
    Ono, Takaaki
    Takeshita, Akihiro
    Iwanaga, Masako
    Asou, Norio
    Naoe, Tomoki
    Ohno, Ryuzo
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (01): : 174 - 176
  • [50] Prospective Evaluation of Prognostic Relevance of KIT Mutations in Core-Binding Factor Acute Myeloid Leukemia: Results from the JALSG CBF-AML209-KIT Study
    Kawashima, Naomi
    Ishikawa, Yuichi
    Atsuta, Yoshiko
    Sugiura, Isamu
    Sawa, Masashi
    Dobashi, Nobuaki
    Yokoyama, Hisayuki
    Doki, Noriko
    Tomita, Akihiro
    Kiguchi, Toru
    Koh, Shiro
    Kanamori, Heiwa
    Iriyama, Noriyoshi
    Kohno, Akio
    Moriuchi, Yukiyoshi
    Asada, Noboru
    Hirano, Daiki
    Togitani, Kazuto
    Sakura, Toru
    Hagihara, Maki
    Tomikawa, Tatsuki
    Yokoyama, Yasuhisa
    Asou, Norio
    Ohtake, Shigeki
    Matsumura, Itaru
    Miyazaki, Yasushi
    Naoe, Tomoki
    Kiyoi, Hitoshi
    BLOOD, 2018, 132